Mayo Clinic has bet on chronic disease drug developer Novome Biotechnologies, which is initially targeting a disorder known as hyperoxaluria.

Foxconn, Chow Tai Fook, Hogy Medical and Varian Medical have all invested in a round that took the surgical robot developer's total financing to $160m.

The DNA sequencing technology developer, which counts Nan Fung and Lam Research as investors, has added $60m to take its funding to $145m in the last 18 months.

The healthcare scheduling software provider boosted its total funding to almost $120m in a round backed by Providence Ventures and Salesforce Ventures.

Roche Venture Fund led a $14.1m extension for Jasper Therapeutics, developer of a conditioning agent for haematopoietic cell transplants, boosting the round to more than $49m.

McKesson-backed healthcare macrodata platform developer Komodo Health snagged the cash in a series C round led by Andreessen Horowitz.

Stanford-StartX Fund-backed Inflammatix received series C funding led by Grey Sky ahead of the European release of its acute infection diagnostics platform.

Salesforce, Dignity Health and McKesson have exited patient engagement software developer Evariant, which had raised more than $86m pre-acquisition.

The cancer antibody drug conjugate developer secured the return of Boehringer Ingelheim Venture Fund ahead of early clinical trials on its lead candidate.

The round included a $10m investment by Ionis Pharmaceuticals which was provided as part of a collaboration agreement.